CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

COVID-19 UpdateAnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

View More Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

Analytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

News

All News Top News Industry News Bio/Pharma News Supplier News News from Europe Events

All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents

Publications

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Resources

Front & Center Pharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts Marketplace

Multimedia

Drug Solutions Podcast

Enewsletters Magazine North America Magazine Europe

EnewslettersMagazine North AmericaMagazine Europe

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Dosage Forms
Drug Development
Manufacturing
Outsourcing
Quality Systems

TopicSee All >

Analytical Method Development
APIs
Aseptic Processing
Biologic Drugs
Drug Delivery
Equipment
Excipients
Formulation
Packaging
Process Control/PAT
Process Development
QA/QC
Regulatory Action
Supply Chain

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Dosage Forms

home

Getting a Nose for Vaccines

Intranasal vaccines are showing promise, but there are multiple formulation hurdles to overcome.

Delivery platforms for inhalation drugs; image: Gluiki - Stock.adobe.com

Platform Decisions for Inhalation Drugs

The delivery platform depends on API-related factors, and the development stage of the product.

Drug Solutions Podcast: 2022 Bio/pharma Trends: US-Based Suppliers, Digitization, and Sustainability

January 18, 2022

In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.

Sustainable Shippers for Ultra-Cold Conditions

January 17, 2022

Protective external packaging ensures COVID-19 vaccines arrive safely.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System

January 11, 2022

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Clinical Trial on Intranasal Coronavirus Vaccine Set to Start

January 07, 2022

Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study.

Troubleshooting Using Predictive Maintenance

January 06, 2022

Smart manufacturing transforms management of tablet and capsule equipment and processes.

Addressing the Training Gap for Single-Use Technologies

January 03, 2022

Workforce training is crucial for biopharmaceutical manufacturing.

ISPE Publishes Guide for ATMP Facilities

December 10, 2021

Guide addresses challenges of applying GMPs to autologous cell therapy manufacturing.

Fujifilm Irvine Scientific Builds Bioprocessing Innovation and Collaboration Center in China

December 03, 2021

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.

It’s a Matter of Taste-Masking

December 03, 2021

Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.

CordenPharma Adds Highly Potent Capabilities in Germany

December 01, 2021

CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.